Novo Nordisk A/S (NVO) stock fundamentals

Valuation

Market cap

USD 171.73B

P/E (trailing)

9.42

P/E (forward)

11.44

PEG ratio

2.13

Price / sales

3.53

Price / book

5.63

EV / EBITDA

7.7x

Dividend yield

4.59%

Profitability

Gross margin

82.0%

Operating margin

42.5%

Net margin

35.3%

Return on equity

59.8%

Growth (year over year)

Revenue growth

2.1%

Earnings growth

-20.6%

Balance sheet & cash flow

Total cash

USD 6.71B

Total debt

USD 20.90B

Free cash flow

USD 5.62B

Current ratio

0.87

Price range

52-week low

USD 35.12

52-week high

USD 64.16

About Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral…

Employees: 66,700

Go deeper on NVO

The free Fundamentals tool adds multi-year revenue, earnings, margin, cash flow and debt history, P/E and valuation trends, Piotroski, Altman and Beneish health scores, and dividend history. Learn how to read them in how to analyse stock fundamentals.

Other popular stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Amazon (AMZN)Alphabet (GOOGL)Meta Platforms (META)Tesla (TSLA)Broadcom (AVGO)Berkshire Hathaway (BRK-B)JPMorgan Chase (JPM)Visa (V)Mastercard (MA)Eli Lilly (LLY)UnitedHealth (UNH)Exxon Mobil (XOM)Costco (COST)Walmart (WMT)Netflix (NFLX)AMD (AMD)Palantir (PLTR)Oracle (ORCL)Salesforce (CRM)Adobe (ADBE)Intel (INTC)